Biomerica Announces Third Quarter Financial Results
April 15, 2020 08:30 ET
|
Biomerica, Inc.
IRVINE, Calif., April 15, 2020 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) today reported net sales of $3,967,712 for the nine months ending February 29, 2020, compared to $4,034,822 for the...
Biomerica Signs Two Definitive Agreements with Mount Sinai Medical School in New York to Scale-up a Laboratory Version Serological Test for COVID-19 That Enables High-Volume Screenings in Labs
April 02, 2020 07:38 ET
|
Biomerica, Inc.
Price point of this high-volume laboratory version test is expected be as low as $10 per patient Once developed and scaled-up, Biomerica’s existing production capacity could allow for over 1,000,000...
Biomerica Begins Shipping Samples of 10 Minute Test for COVID-19 Virus Exposure
March 17, 2020 20:16 ET
|
Biomerica, Inc.
10-minute test for coronavirus exposure utilizing blood from a finger prick can be performed anywhere by trained professionals, e.g. airports, schools, work, doctor’s office Biomerica has begun...
Biomerica Announces $2.0 Million Investment by Palm Global Small Cap Master Fund
February 26, 2020 16:41 ET
|
Biomerica, Inc.
IRVINE, Calif., Feb. 26, 2020 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA) (the “Company” or “Biomerica”) announced today that the Company completed a private placement of $2 million of...
Biomerica Announces Second Quarter Financial Results; Sales Up 6.4% for the Quarter
January 15, 2020 08:19 ET
|
Biomerica, Inc.
IRVINE, Calif., Jan. 15, 2020 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) today reported net sales of $1,596,408 for the three months ended November 30, 2019, compared to $1,500,791 for the...
Houston Methodist (part of Texas Medical Center) to start patient enrollment for Biomerica’s InFoods® Irritable Bowel Syndrome (IBS) diagnostic guided therapy clinical trial
January 07, 2020 08:19 ET
|
Biomerica, Inc.
Texas Medical Center is the largest medical complex in the world with 10 million patient encounters per year and a 1,345-acre campus (50 million square feet of developed facilities)InFoods® Diagnostic...
Biomerica Reports 1st Quarter Fiscal 2020 Financials
October 16, 2019 08:19 ET
|
Biomerica, Inc.
IRVINE, Calif., Oct. 16, 2019 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) today reported net sales of $1,194,415 for the three months ending August 31, 2019, compared to $1,272,870 for the...
Biomerica Announces Fiscal Year End 2019 Financial Results
August 30, 2019 08:30 ET
|
Biomerica, Inc.
IRVINE, Calif., Aug. 30, 2019 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a global provider of advanced medical products, today reported net sales for the fiscal year 2019 were $5,200,682...
Republic of Colombia’s food and drug regulatory agency grants clearance for Biomerica’s colorectal cancer screening test to be sold in Colombia
August 21, 2019 08:19 ET
|
Biomerica, Inc.
IRVINE, Calif., Aug. 21, 2019 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) announced the Republic of Colombia Ministry of Health and Social Protection Institute National Surveillance of Drugs...
Biomerica signs exclusive distribution agreement in China for its colorectal screening test with total minimum purchase requirement of $17 million over 7 years and an upfront pre-payment of $1 million.
June 05, 2019 08:19 ET
|
Biomerica, Inc.
IRVINE, Calif., June 05, 2019 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) announced it has signed an exclusive sales and distribution agreement with MaxHealth for the sale of its EZ Detect...